News from quanterix corporation

( EuronextParis:BIM)

Oct 11, 2012, 09:00 ET

Quanterix's Ultrasensitive Simoa™ Technology Demonstrates Equivalence with NAT and 3,000x Improvement in Sensitivity over Conventional Immunoassays for HIV Detection

 Quanterix Corporation announced today that the Journal of Virological Methods published a key study describing the application of its...

Jul 20, 2012, 11:36 ET

Quanterix Appoints Paul Chapman as President and Chief Executive Officer

 Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its...

Feb 09, 2012, 12:00 ET

Quanterix to Collaborate With the Forsyth Institute and Beth Israel Deaconess Medical Center to Develop Tuberculosis Test

 Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Jan 05, 2012, 08:30 ET

Quanterix Announces Strategic Investment From IQT

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Dec 22, 2011, 08:30 ET

Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology

 Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule...

Dec 01, 2011, 08:30 ET

Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Nov 02, 2011, 08:30 ET

Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Oct 13, 2011, 11:00 ET

Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Sep 19, 2011, 10:37 ET

Dr. Martin Madaus Joins Quanterix as CEO

Quanterix Corporation, using its revolutionary Single Molecule Array (SiMoA™) technology to enable unprecedented high value research and...

Aug 19, 2011, 10:02 ET

Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohn's Disease

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Aug 16, 2011, 08:00 ET

Quanterix and STRATEC Announce Strategic Partnership

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...

Jul 21, 2011, 09:00 ET

Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance

Quanterix Corporation, an in-vitro diagnostics (IVD) company providing life science researchers and IVD labs single molecule technology with...

Jul 20, 2011, 08:00 ET

Quanterix and Sony DADC to Develop and Manufacture Smart Consumables for Life Science and In Vitro Diagnostic Applications

Quanterix Corporation, enabling a new generation of diagnostic tests based on the revolutionary Single Molecule Array (SiMoA™) technology,...

Apr 12, 2011, 13:30 ET

Quanterix Discovers Link Between Heart Attack-Induced Hypoxia and Suspected Alzheimer's Disease Pathway

Quanterix Corporation, enabling a new generation of diagnostics based on revolutionary Single Molecule Array (SiMoA™) technology, today...

Feb 23, 2011, 10:38 ET

Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability

Quanterix Corporation, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro...

Feb 22, 2011, 07:30 ET

Quanterix Announces New Technology Evaluation Agreement

Quanterix Corporation, enabling a new generation of diagnostic tests based on revolutionary Single Molecule Array (SiMoA™) technology, today...

Dec 01, 2010, 08:30 ET

Dr. Martin Madaus Joins Quanterix Board of Directors

Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company's Board as Executive Chairman. Dr. Madaus brings more than...

Nov 02, 2010, 12:26 ET

Quanterix Awarded $733,437 in Qualifying Therapeutic Discovery Project (QTDP) Grants

Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it...

May 23, 2010, 13:00 ET

Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer

Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the...

Sep 02, 2009, 09:00 ET

Dr. David Okrongly Appointed CEO of Quanterix Corporation

Quanterix Corporation, the leader in single molecule detection, announced today that David Okrongly, Ph.D. has been appointed Chief Executive...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review